<unk>  is a alpha-adrenergic blocker that is FDA approved for the {{{indicationType}}} of symptomatic benign prostatic hyperplasia (BPH) and hypertension.   Common adverse reactions include orthostatic hypotension, palpitations, peripheral edema, nausea, asthenia, dizziness headache, somnolence and nasal congestion.
Terazosin
Doxazosin
Trimazosin
Isoxsuprine
Silodosin
Oxymetazoline
Methylergonovine 
Tilmicosin